1 study on Egfr signaling mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GHRH antagonists like JMR-132 may represent a mechanistically distinct antiproliferative strategy** for ovarian cancers expressing SV1 of the GHRH receptor, targeting the `EGFR-Akt` axis without being a direct EGFR …